Cargando…

Clinical response to everolimus in a patient with Hodgkin's lymphoma harboring a TSC2 mutation

Detalles Bibliográficos
Autores principales:	Perini, G F, Campregher, P V, Ross, J S, Ali, S, Hamerschlak, N, Santos, F P S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916294/ https://www.ncbi.nlm.nih.gov/pubmed/27176796 http://dx.doi.org/10.1038/bcj.2016.25

Ejemplares similares

Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2
por: Kwiatkowski, David J, et al.
Publicado: (2015)

Cutaneous Hodgkin's lymphoma
por: Ambekar, Asawari Anant, et al.
Publicado: (2017)

Everolimus for the treatment of CD20+ diffuse large B-cell lymphoma in a renal allograft recipient
por: Kute, V. B., et al.
Publicado: (2012)

Combination of Everolimus with Sorafenib for Solid Renal Tumors in Tsc2(+/−) Mice Is Superior to Everolimus Alone()
por: Yang, Jian, et al.
Publicado: (2017)

Hodgkin's lymphoma masquerading as suppurative lymphadenitis
por: Singh, Meghna, et al.
Publicado: (2017)

Non-Hodgkin lymphoma mimicking cholangiocarcinoma
por: Mendes, Gustavo Gomes, et al.
Publicado: (2019)

PET/CT and brown fat in the evaluation of treatment response in Hodgkin lymphoma
por: Pessanha, Laís Bastos, et al.
Publicado: (2015)

Genetic susceptibility to therapy-related leukemia after Hodgkin lymphoma or non-Hodgkin lymphoma: role of drug metabolism, apoptosis and DNA repair
por: Ding, Y, et al.
Publicado: (2012)

Treatment response to idelalisib in a patient with immunodeficiency-associated Burkitt lymphoma harboring a PIK3CA H1047R mutation
por: Bleckmann, Annalen, et al.
Publicado: (2020)

Heritability of childhood leukaemia and non-Hodgkin lymphoma
por: Hawkins, M M, et al.
Publicado: (1996)

Severe neurotoxicity due to Vinblastine in Hodgkin lymphoma
por: Suresh, Pandalanghat, et al.
Publicado: (2014)

Bilateral Primary Adrenal Non-Hodgkin Lymphoma
por: Erçolak, Vehbi, et al.
Publicado: (2014)

Profile of non-Hodgkin lymphoma: An Indian perspective
por: Gogia, Ajay, et al.
Publicado: (2018)

The Insights of Head and Neck Non-Hodgkin Lymphoma
por: Wan Abdul Rahman, Wan Faiziah, et al.
Publicado: (2020)

Hodgkin Lymphoma, Tuberculosis, and Atypical Radiologic Image
por: Yasri, Sora, et al.
Publicado: (2019)

Sporadic multiple meningiomas harbor distinct driver mutations
por: Juratli, Tareq A., et al.
Publicado: (2021)

Phase 2 study of everolimus for relapsed or refractory classical Hodgkin lymphoma
por: Johnston, Patrick B., et al.
Publicado: (2018)

Exceptional Response to Everolimus in a Patient with Metastatic Castrate-Resistant Prostate Cancer Harboring a PTEN Inactivating Mutation
por: Kmak, Jamie A., et al.
Publicado: (2020)

Simultaneous Presence of Follicular Lymphoma, Diffuse Large B-cell Lymphoma, and Hodgkin-like Lymphoma
por: Papoudou-Bai, Alexandra, et al.
Publicado: (2018)

Prevalence of non-Hodgkin lymphomas in São Paulo, Brazil
por: Gouveia, Gisele Rodrigues, et al.
Publicado: (2011)

Paraspinal mass as a presentation in relapsed Hodgkin lymphoma
por: Dua, Vikas, et al.
Publicado: (2013)

Occurrence of sarcoidosis after chemotherapy for non-Hodgkin lymphoma
por: Cho, Hyungwoo, et al.
Publicado: (2016)

Primary bilateral non-Hodgkin's lymphoma of the adrenal gland
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2019)

Primary Non-Hodgkin's Lymphoma of the Duodenum: An Uncommon Location
por: Ravikanth, Reddy, et al.
Publicado: (2019)

Sarcoid-like reaction: Hodgkin’s lymphoma is a hypothesis
por: Oliveira, Cristiano Claudino
Publicado: (2020)

A phase II study of everolimus in patients with advanced solid malignancies with TSC1, TSC2, NF1, NF2 or STK11 mutations
por: Devarakonda, Siddhartha, et al.
Publicado: (2021)

Nodular Lymphocyte-Predominant Hodgkin Lymphoma in a Patient with Familial Mediterranean Fever
por: Belia, Marina, et al.
Publicado: (2022)

Treatment pathways and resource use associated with recurrent Hodgkin lymphoma after autologous stem cell transplantation
por: Radford, J, et al.
Publicado: (2017)

Lenalidomide induced good clinical response in a patient with multiple relapsed and refractory Hodgkin's lymphoma
por: Mandac, Inga, et al.
Publicado: (2010)

Excellent response of solifenacin in chemotherapy-induced hemorrhagic cystitis in a child with non-Hodgkin's lymphoma
por: Mahawar, Bablesh, et al.
Publicado: (2018)

Metronomic combination chemotherapy using everolimus and etoposide for the treatment of non‐Hodgkin lymphoma
por: Wu, Ke, et al.
Publicado: (2019)

Ocular surface squamous neoplasia inpatient with non-Hodgkin's lymphoma
por: Joshi, Rajesh Subhash
Publicado: (2017)

Synchronous Nodal Involvement of Metastatic Adenocarcinoma and Classical Hodgkin’s Lymphoma
por: Sachdev, Ritesh, et al.
Publicado: (2017)

Cervical Radiculopathy as the Inaugural Manifestation of Non-Hodgkin's Lymphoma of Rib
por: Puranik, Monika, et al.
Publicado: (2021)

Everolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutation
por: Hwang, Su-Kyeong, et al.
Publicado: (2016)

Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial
por: Franz, David N., et al.
Publicado: (2018)

Atypical Radiologic Image Characterized by Cavitary Lung Lesions in a Case of Hodgkin Lymphoma
por: Büyükşimşek, Mahmut, et al.
Publicado: (2019)

Everolimus as a single agent in refractory or relapsed Hodgkin's lymphoma: the Brazilian Named Patient Program Experience
por: Rocha, Talita Máira Bueno da Silveira da, et al.
Publicado: (2017)

HIV Co-receptor usage in HIV-related non-hodgkin's lymphoma
por: Reid, Erin, et al.
Publicado: (2012)

Central Nervous System Involvement in Primary Adrenal Non-Hodgkin Lymphoma
por: Somanath, Padhi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mgvtisn0hcvj9ub5886a636roe